These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1005 related articles for article (PubMed ID: 10218971)

  • 1. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey.
    Shridhar S; Farley A; Reid RL; Foster WG; Van Vugt DA
    Toxicol Sci; 2001 Oct; 63(2):181-8. PubMed ID: 11568361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oestradiol and progesterone on hypoglycaemic stress-induced suppression of pulsatile luteinizing hormone release and on corticotropin-releasing hormone mRNA expression in the rat.
    Li XF; Mitchell JC; Wood S; Coen CW; Lightman SL; O'Byrne KT
    J Neuroendocrinol; 2003 May; 15(5):468-76. PubMed ID: 12694372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
    Ma XM; Levy A; Lightman SL
    Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys.
    Bethea CL; Centeno ML
    Neuropsychopharmacology; 2008 Feb; 33(3):546-56. PubMed ID: 17507918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of salt-loading on corticotropin releasing hormone and arginine vasopressin mRNA levels in the mouse hypothalamus: a quantitative in situ hybridization analysis.
    Tracer HL; Loh YP
    Neuropeptides; 1993 Sep; 25(3):161-7. PubMed ID: 8247254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice.
    Nomura M; Saito J; Ueta Y; Muglia LJ; Pfaff DW; Ogawa S
    J Neuroendocrinol; 2003 Nov; 15(11):1054-61. PubMed ID: 14622435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone heterogeneous nuclear RNA (hnRNA) and immunoreactivity are induced in extrahypothalamic brain sites by kainic-acid-induced seizures and are modulated by estrogen.
    Foradori CD; Lund TD; Nagahara AH; Koenig JI; Handa RJ
    Brain Res; 2007 Aug; 1164():44-54. PubMed ID: 17631870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement.
    Ogasa T; Hashimoto K; Suemaru S; Kageyama J; Ota Z
    Brain Res; 1992 Jun; 583(1-2):45-53. PubMed ID: 1504843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression.
    Herman JP; Cullinan WE; Young EA; Akil H; Watson SJ
    Brain Res; 1992 Oct; 592(1-2):228-38. PubMed ID: 1333341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus.
    Albeck DS; Hastings NB; McEwen BS
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):129-34. PubMed ID: 7854039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
    Schwartz MW; Strack AM; Dallman MF
    Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.
    Arima H; Aguilera G
    J Neuroendocrinol; 2000 Sep; 12(9):833-42. PubMed ID: 10971808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei.
    Nomura M; Ueta Y; Serino R; Yamamoto Y; Shibuya I; Yamashita H
    Neuroendocrinology; 1999 Mar; 69(3):167-80. PubMed ID: 10087449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential exposure to estrogen and testosterone (T) and subsequent withdrawal of T increases the level of arginine vasopressin messenger ribonucleic acid in the hypothalamic paraventricular nucleus of the female rat.
    Thomas A; Kim NB; Amico JA
    J Neuroendocrinol; 1996 Oct; 8(10):793-800. PubMed ID: 8910810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hyperosmotic stimulation and adrenalectomy on vasopressin mRNA levels in the paraventricular and supraoptic nuclei of the hypothalamus: in situ hybridization histochemical analysis using a synthetic oligonucleotide probe.
    Suemaru S; Hashimoto K; Ogasa T; Takao T; Ota Z; Hirakawa M; Kawata M
    Acta Med Okayama; 1990 Oct; 44(5):233-41. PubMed ID: 2260495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V; Soriano L; Dallman MF
    J Neuroendocrinol; 2001 May; 13(5):442-52. PubMed ID: 11328455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.